NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 348 filers reported holding NEKTAR THERAPEUTICS in Q4 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2 | -99.9% | 237 | -5.2% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -40.0% | 250 | -37.5% | 0.00% | – |
| Q1 2022 | $5,000 | +400.0% | 400 | +1042.9% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | -50.0% | 35 | -45.3% | 0.00% | – |
| Q1 2020 | $2,000 | – | 64 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q1 2019 | $21,000 | -43.2% | 619 | -43.6% | 0.00% | +50.0% |
| Q4 2018 | $37,000 | -78.1% | 1,097 | -60.5% | 0.00% | -71.4% |
| Q3 2018 | $169,000 | +108.6% | 2,775 | +67.8% | 0.01% | +133.3% |
| Q2 2018 | $81,000 | -19.8% | 1,654 | -2.4% | 0.00% | -40.0% |
| Q1 2018 | $101,000 | 0.0% | 1,694 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $101,000 | +152.5% | 1,694 | +0.5% | 0.01% | +150.0% |
| Q3 2017 | $40,000 | +21.2% | 1,686 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $33,000 | -45.9% | 1,686 | -34.8% | 0.00% | -66.7% |
| Q1 2017 | $61,000 | +205.0% | 2,586 | +55.3% | 0.00% | +200.0% |
| Q4 2016 | $20,000 | -28.6% | 1,665 | +0.7% | 0.00% | 0.0% |
| Q3 2016 | $28,000 | +33.3% | 1,653 | +10.2% | 0.00% | 0.0% |
| Q2 2016 | $21,000 | 0.0% | 1,500 | +142.3% | 0.00% | -66.7% |
| Q1 2016 | $21,000 | -22.2% | 619 | -61.0% | 0.00% | +50.0% |
| Q4 2015 | $27,000 | – | 1,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |